Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.75% |
| 2 | Healthcare | 9.01% |
| 3 | Technology | 7.75% |
| 4 | Financials | 7.01% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Vanguard Extended Market ETF
VXF
$31.7B
| $4.73M | 0.01% |
+40,000
| New | +$4.29M |
|
|
AMRS
1777
DELISTED
Amyris Inc.
AMRS
| $4.73M | 0.01% |
1,108,656
+654,037
| +144% | +$2.17M |
|
1778
Fair Isaac
FICO
$25B
| $4.73M | 0.01% |
11,319
-45,661
| -80% | -$16.7M |
|
|
GMHIU
1779
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
| $4.73M | 0.01% |
420,000
| – | – |
|
1780
Howard Hughes
HHH
$3.88B
| $4.71M | 0.01% |
95,188
-24,833
| -21% | -$1.25M |
|
|
ISEE
1781
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.71M | 0.01% |
922,964
-425,536
| -32% | -$1.77M |
|
1782
PUT
Hershey
HSY
$36.4B
| $4.71M | 0.01% |
36,300
+30,700
| +548% | +$4.13M |
|
1783
CarMax
KMX
$8.89B
| $4.7M | 0.01% |
52,496
-114,805
| -69% | -$9M |
|
|
IPG
1784
DELISTED
Interpublic Group of Companies
IPG
| $4.69M | 0.01% |
+273,560
| New | +$4.51M |
|
1785
LivePerson
LPSN
$34.4M
| $4.69M | 0.01% |
+7,554
| New | +$3.52M |
|
1786
National Health Investors
NHI
$3.56B
| $4.68M | 0.01% |
77,082
-161,634
| -68% | -$8.88M |
|
1787
Red Robin
RRGB
$178M
| $4.67M | 0.01% |
458,371
+441,058
| +2,548% | +$5.56M |
|
|
FMBI
1788
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $4.67M | 0.01% |
350,090
+85,583
| +32% | +$1.14M |
|
1789
CALL
Dollar General
DG
$27.8B
| $4.67M | 0.01% |
24,500
+5,100
| +26% | +$923K |
|
|
SKX
1790
DELISTED
Skechers
SKX
| $4.67M | 0.01% |
148,647
+89,518
| +151% | +$2.57M |
|
1791
J&J Snack Foods
JJSF
$1.64B
| $4.66M | 0.01% |
36,677
-60,245
| -62% | -$7.57M |
|
1792
Hess Midstream
HESM
$5.11B
| $4.65M | 0.01% |
253,866
+71,565
| +39% | +$1.19M |
|
1793
CALL
Paychex
PAYX
$45B
| $4.65M | 0.01% |
61,400
| – | – |
|
1794
Apogee Enterprises
APOG
$848M
| $4.64M | 0.01% |
201,604
-165,851
| -45% | -$3.39M |
|
1795
McCormick & Company Non-Voting
MKC
$14.7B
| $4.64M | 0.01% |
51,706
-47,948
| -48% | -$3.95M |
|
1796
Oxford Industries
OXM
$570M
| $4.63M | 0.01% |
105,231
+81,464
| +343% | +$3.39M |
|
1797
iShares Floating Rate Bond ETF
FLOT
$10.6B
| $4.62M | 0.01% |
+91,392
| New | +$4.57M |
|
1798
Protolabs
PRLB
$1.92B
| $4.62M | 0.01% |
41,089
-69,306
| -63% | -$7.11M |
|
1799
Madrigal Pharmaceuticals
MDGL
$12.6B
| $4.62M | 0.01% |
40,775
-9,972
| -20% | -$981K |
|
|
UBX
1800
DELISTED
Unity Biotechnology
UBX
| $4.62M | 0.01% |
53,205
+50,128
| +1,629% | +$3.72M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $10.9B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.